These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10946253)

  • 1. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease.
    Liu MT; Chen BP; Oertel P; Buchmeier MJ; Armstrong D; Hamilton TA; Lane TE
    J Immunol; 2000 Sep; 165(5):2327-30. PubMed ID: 10946253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system.
    Liu MT; Armstrong D; Hamilton TA; Lane TE
    J Immunol; 2001 Feb; 166(3):1790-5. PubMed ID: 11160225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking.
    Dufour JH; Dziejman M; Liu MT; Leung JH; Lane TE; Luster AD
    J Immunol; 2002 Apr; 168(7):3195-204. PubMed ID: 11907072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.
    Skinner D; Marro BS; Lane TE
    Viral Immunol; 2019; 32(1):25-37. PubMed ID: 30109979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection.
    Stiles LN; Hardison JL; Schaumburg CS; Whitman LM; Lane TE
    J Immunol; 2006 Dec; 177(12):8372-80. PubMed ID: 17142734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles for CXCR3 in CD4+ and CD8+ T cell trafficking following viral infection of the CNS.
    Stiles LN; Hosking MP; Edwards RA; Strieter RM; Lane TE
    Eur J Immunol; 2006 Mar; 36(3):613-22. PubMed ID: 16479546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXC chemokines IP-10 and Mig are essential in host defense following infection with a neurotropic coronavirus.
    Liu MT; Chen BP; Oertel P; Buchmeier MJ; Hamilton TA; Armstrong DA; Lane TE
    Adv Exp Med Biol; 2001; 494():323-7. PubMed ID: 11774487
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis.
    Liu MT; Keirstead HS; Lane TE
    J Immunol; 2001 Oct; 167(7):4091-7. PubMed ID: 11564831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease.
    Walsh KB; Edwards RA; Romero KM; Kotlajich MV; Stohlman SA; Lane TE
    J Immunol; 2007 Jul; 179(2):1155-65. PubMed ID: 17617609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses.
    Hwang M; Bergmann CC
    J Virol; 2018 May; 92(10):. PubMed ID: 29491163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR1 deficiency increases susceptibility to fatal coronavirus infection of the central nervous system.
    Hickey MJ; Held KS; Baum E; Gao JL; Murphy PM; Lane TE
    Viral Immunol; 2007 Dec; 20(4):599-608. PubMed ID: 18158733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis.
    Fife BT; Kennedy KJ; Paniagua MC; Lukacs NW; Kunkel SL; Luster AD; Karpus WJ
    J Immunol; 2001 Jun; 166(12):7617-24. PubMed ID: 11390519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myd88 Initiates Early Innate Immune Responses and Promotes CD4 T Cells during Coronavirus Encephalomyelitis.
    Butchi N; Kapil P; Puntambekar S; Stohlman SA; Hinton DR; Bergmann CC
    J Virol; 2015 Sep; 89(18):9299-312. PubMed ID: 26136579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR3 and IFN protein-10 in Pneumocystis pneumonia.
    McAllister F; Ruan S; Steele C; Zheng M; McKinley L; Ulrich L; Marrero L; Shellito JE; Kolls JK
    J Immunol; 2006 Aug; 177(3):1846-54. PubMed ID: 16849496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protective role for ELR+ chemokines during acute viral encephalomyelitis.
    Hosking MP; Liu L; Ransohoff RM; Lane TE
    PLoS Pathog; 2009 Nov; 5(11):e1000648. PubMed ID: 19893623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection.
    Cervantes-Barragán L; Firner S; Bechmann I; Waisman A; Lahl K; Sparwasser T; Thiel V; Ludewig B
    J Immunol; 2012 Apr; 188(8):3678-85. PubMed ID: 22407917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection.
    Bergmann CC; Ramakrishna C; Kornacki M; Stohlman SA
    J Immunol; 2001 Aug; 167(3):1575-83. PubMed ID: 11466379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the Th1 chemokine IFN-gamma-inducible protein 10 in the airway alters mucosal allergic sensitization in mice.
    Wiley R; Palmer K; Gajewska B; Stämpfli M; Alvarez D; Coyle A; Gutierrez-Ramos J; Jordana M
    J Immunol; 2001 Feb; 166(4):2750-9. PubMed ID: 11160341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.
    Ramos SJ; Hardison JL; Stiles LN; Lane TE; Walsh CM
    Autoimmunity; 2007 Feb; 40(1):54-65. PubMed ID: 17364498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis.
    Tschen SI; Bergmann CC; Ramakrishna C; Morales S; Atkinson R; Stohlman SA
    J Immunol; 2002 Mar; 168(6):2922-9. PubMed ID: 11884463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.